{"id":12380,"date":"2024-06-12T01:01:43","date_gmt":"2024-06-11T23:01:43","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=12380"},"modified":"2026-03-03T10:38:17","modified_gmt":"2026-03-03T09:38:17","slug":"communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/","title":{"rendered":"Communiqu\u00e9 de presse: Disponibilit\u00e9 des m\u00e9dicaments: la Suisse perd du terrain"},"content":{"rendered":"\n<p class=\"is-style-paragraph-lead-text\"><strong>En Suisse, l\u2019acc\u00e8s des patient-e-s \u00e0 des m\u00e9dicaments parfois vitaux se d\u00e9grade de plus en plus. L\u2019\u00e9tude de l\u2019EFPIA \u00abPatients W.A.I.T. Indicator\u00bb souligne que la Suisse perd du terrain en mati\u00e8re de disponibilit\u00e9 des m\u00e9dicaments innovants. Du point de vue de l\u2019industrie pharmaceutique pratiquant la recherche, le besoin d\u2019agir est patent: il faut d\u2019urgence acc\u00e9l\u00e9rer et moderniser l\u2019acc\u00e8s des patient-e-s aux m\u00e9dicaments. Le Parlement dispose de propositions en ce sens. <\/strong><\/p>\n\n\n\n<p>Chaque ann\u00e9e, l\u2019EFPIA compare la disponibilit\u00e9 des m\u00e9dicaments dans les diff\u00e9rents pays d\u2019Europe et publie les r\u00e9sultats dans le \u00abPatients WAIT Indicator\u00bb. Celui-ci rel\u00e8ve entre autres le \u00abFull Rate of Availability\u00bb, c\u2019est-\u00e0-dire la prise en charge g\u00e9n\u00e9rale standard. En Suisse, un m\u00e9dicament autoris\u00e9 n\u2019est disponible pour les patient-e-s qu\u2019une fois que l\u2019Office f\u00e9d\u00e9ral de la sant\u00e9 publique (OFSP) en a fix\u00e9 le prix et a admis le m\u00e9dicament dans ce que l\u2019on appelle la liste des sp\u00e9cialit\u00e9s (LS).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-les-patient-e-s-de-suisse-n-ont-acces-qu-a-la-moitie-des-medicaments-pris-en-charge-en-allemagne\"><strong>Les patient-e-s de Suisse n\u2019ont acc\u00e8s qu\u2019\u00e0 la moiti\u00e9 des m\u00e9dicaments pris en charge en Allemagne<\/strong><\/h2>\n\n\n\n<p>Un coup d\u2019\u0153il \u00e0 la disponibilit\u00e9 des m\u00e9dicaments en Suisse compar\u00e9e \u00e0 l\u2019\u00e9tranger montre que seuls 48% des m\u00e9dicaments autoris\u00e9s par l\u2019EMA figurent en Suisse dans la LS. En comparaison internationale, la Suisse descend ainsi en 6<sup>e<\/sup> position. Par rapport \u00e0 la seule ann\u00e9e pr\u00e9c\u00e9dente, cela repr\u00e9sente une d\u00e9gradation de 6 points.<\/p>\n\n\n\n<p>En outre, une bonne moiti\u00e9 seulement (54%) des m\u00e9dicaments pris en charge en Allemagne figurent aussi en Suisse dans la LS et sont donc disponibles \u00e0 \u00e9galit\u00e9 pour tous\/toutes les patient-e-s. Par rapport \u00e0 l\u2019ann\u00e9e pr\u00e9c\u00e9dente, cela repr\u00e9sente une d\u00e9gradation de 8&nbsp;points, une tendance n\u00e9gative qui se manifeste d\u00e9j\u00e0 depuis des ann\u00e9es.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-il-est-plus-urgent-que-jamais-d-accelerer-la-mise-a-disposition\"><strong>Il est plus urgent que jamais d\u2019acc\u00e9l\u00e9rer la mise \u00e0 disposition<\/strong><\/h2>\n\n\n\n<p>Les donn\u00e9es relev\u00e9es chaque ann\u00e9e par Interpharma confirment que la Suisse a un probl\u00e8me d\u2019acc\u00e8s des patient-e-s: elles montrent que l\u2019attente entre l\u2019autorisation de mise sur le march\u00e9 (AMM) et l\u2019admission dans la LS a nettement augment\u00e9 depuis 2016 et atteint aujourd\u2019hui un record de plus de 300&nbsp;jours. <\/p>\n\n\n\n<p>L\u2019\u00e9tude WAIT souligne la n\u00e9cessit\u00e9 de moderniser profond\u00e9ment le processus obsol\u00e8te de formation des prix et de prise en charge des m\u00e9dicaments actuellement en vigueur. En effet, il ne correspond plus depuis des ann\u00e9es au progr\u00e8s m\u00e9dical. Interpharma a esquiss\u00e9 des solutions qui sont \u00e0 pr\u00e9sent d\u00e9battues dans le cadre des d\u00e9lib\u00e9rations sur le 2<sup>e<\/sup> volet de mesures visant \u00e0 freiner la hausse des co\u00fbts: c\u2019est ainsi que le remboursement de l\u2019acc\u00e8s \u00e0 l\u2019innovation doit am\u00e9liorer le processus en rendant les m\u00e9dicaments disponibles pour les patient-e-s d\u00e8s le jour d\u2019octroi de l\u2019AMM avec prise en charge d\u2019un prix provisoire.<\/p>\n\n\n\n<p>Interpharma attend de l\u2019OFSP, des associations de caisses-maladie et du Parlement qu\u2019ils s\u2019attaquent \u00e0 pr\u00e9sent s\u00e9rieusement conjointement aux probl\u00e8mes s\u00e9rieux d\u2019acc\u00e8s des patient-e-s aux m\u00e9dicaments.<\/p>\n\n\n\n<p>Ren\u00e9 Buholzer, directeur d\u2019Interpharma, souligne:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>\u00abL\u2019\u00e9tude WAIT confirme une fois de plus que l\u2019acc\u00e8s des patient-e-s aux m\u00e9dicaments innovants se d\u00e9grade en Suisse. Il est inacceptable qu\u2019un syst\u00e8me de sant\u00e9 comme le n\u00f4tre ne puisse pas concourir avec des pays comme l\u2019Allemagne en mati\u00e8re de mise \u00e0 disposition des m\u00e9dicaments. Pour que notre prise en charge sanitaire garde sa haute qualit\u00e9, il faut que les cercles politiques modernisent \u00e0 pr\u00e9sent rapidement les processus obsol\u00e8tes. Faute de quoi de plus en plus de patientes et patients en feront les frais.\u00bb<\/em><\/p>\n<\/blockquote>\n\n\n\n<p><\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/interpharma.ch\/wp-content\/uploads\/2024\/06\/WAIT_F-1.png\" alt=\"\" class=\"wp-image-25058\" style=\"width:840px;height:auto\"\/><figcaption class=\"wp-element-caption\">Disponibilit\u00e9 des m\u00e9dicaments en Allemagne et en Suisse. Exemple de lecture: sur un total de 167 m\u00e9dicaments autoris\u00e9s par l\u2019EMA en 2023, 87% \u00e9taient enti\u00e8rement disponibles en Allemagne, contre seulement 48% en Suisse. Source: EFPIA WAIT 2023. (D\u00e9finition: enti\u00e8rement disponibles par le biais de la liste des sp\u00e9cialit\u00e9s \/ en partie disponibles par le biais de l\u2019OAMal art. 71a,b \/ non disponibles signifie non autoris\u00e9s par Swissmedic)<\/figcaption><\/figure>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>En Suisse, l\u2019acc\u00e8s des patient-e-s \u00e0 des m\u00e9dicaments parfois vitaux se d\u00e9grade de plus en plus. L\u2019\u00e9tude de l\u2019EFPIA \u00abPatients W.A.I.T. Indicator\u00bb souligne que la Suisse perd du terrain en mati\u00e8re de disponibilit\u00e9 des m\u00e9dicaments innovants. Du point de vue de l\u2019industrie pharmaceutique pratiquant la recherche, le besoin d\u2019agir est patent: il faut d\u2019urgence acc\u00e9l\u00e9rer [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3251,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[54,120,122,130],"class_list":["post-12380","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-medien-fr","tag-innovation-fr","tag-communique-de-presse","tag-pharmastandort-2030-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Communiqu\u00e9 de presse: Disponibilit\u00e9 des m\u00e9dicaments: la Suisse perd du terrain - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9 de presse: Disponibilit\u00e9 des m\u00e9dicaments: la Suisse perd du terrain\" \/>\n<meta property=\"og:description\" content=\"En Suisse, l\u2019acc\u00e8s des patient-e-s \u00e0 des m\u00e9dicaments parfois vitaux se d\u00e9grade de plus en plus. L\u2019\u00e9tude de l\u2019EFPIA \u00abPatients W.A.I.T. Indicator\u00bb souligne que la Suisse perd du terrain en mati\u00e8re de disponibilit\u00e9 des m\u00e9dicaments innovants. Du point de vue de l\u2019industrie pharmaceutique pratiquant la recherche, le besoin d\u2019agir est patent: il faut d\u2019urgence acc\u00e9l\u00e9rer [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-11T23:01:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T09:38:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Wait_F2-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Communiqu\u00e9 de presse: Disponibilit\u00e9 des m\u00e9dicaments: la Suisse perd du terrain\",\"datePublished\":\"2024-06-11T23:01:43+00:00\",\"dateModified\":\"2026-03-03T09:38:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/\"},\"wordCount\":735,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Wait_F2-2.png\",\"keywords\":[\"M\u00e9dias\",\"Innovation\",\"Communiqu\u00e9 de presse\",\"Pharmastandort 2030\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/\",\"url\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/\",\"name\":\"Communiqu\u00e9 de presse: Disponibilit\u00e9 des m\u00e9dicaments: la Suisse perd du terrain - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Wait_F2-2.png\",\"datePublished\":\"2024-06-11T23:01:43+00:00\",\"dateModified\":\"2026-03-03T09:38:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Wait_F2-2.png\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Wait_F2-2.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse: Disponibilit\u00e9 des m\u00e9dicaments: la Suisse perd du terrain\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse: Disponibilit\u00e9 des m\u00e9dicaments: la Suisse perd du terrain - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/","og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9 de presse: Disponibilit\u00e9 des m\u00e9dicaments: la Suisse perd du terrain","og_description":"En Suisse, l\u2019acc\u00e8s des patient-e-s \u00e0 des m\u00e9dicaments parfois vitaux se d\u00e9grade de plus en plus. L\u2019\u00e9tude de l\u2019EFPIA \u00abPatients W.A.I.T. Indicator\u00bb souligne que la Suisse perd du terrain en mati\u00e8re de disponibilit\u00e9 des m\u00e9dicaments innovants. Du point de vue de l\u2019industrie pharmaceutique pratiquant la recherche, le besoin d\u2019agir est patent: il faut d\u2019urgence acc\u00e9l\u00e9rer [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/","og_site_name":"Interpharma","article_published_time":"2024-06-11T23:01:43+00:00","article_modified_time":"2026-03-03T09:38:17+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Wait_F2-2.png","type":"image\/png"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"berta_admin","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Communiqu\u00e9 de presse: Disponibilit\u00e9 des m\u00e9dicaments: la Suisse perd du terrain","datePublished":"2024-06-11T23:01:43+00:00","dateModified":"2026-03-03T09:38:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/"},"wordCount":735,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Wait_F2-2.png","keywords":["M\u00e9dias","Innovation","Communiqu\u00e9 de presse","Pharmastandort 2030"],"inLanguage":"fr-FR","copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/","name":"Communiqu\u00e9 de presse: Disponibilit\u00e9 des m\u00e9dicaments: la Suisse perd du terrain - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Wait_F2-2.png","datePublished":"2024-06-11T23:01:43+00:00","dateModified":"2026-03-03T09:38:17+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Wait_F2-2.png","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/06\/Wait_F2-2.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse: Disponibilit\u00e9 des m\u00e9dicaments: la Suisse perd du terrain"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=12380"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12380\/revisions"}],"predecessor-version":[{"id":12381,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12380\/revisions\/12381"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/3251"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=12380"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=12380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}